Rational Application of First-Line EGFR-TKIs Combined with Antiangiogenic Inhibitors in Advanced EGFR-Mutant Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis

PURPOSE: A meta-analysis of randomized controlled trials (RCTs) was conducted to compare the difference in efficacy and safety between epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) with antiangiogenic inhibitors (A + T) and EGFR-TKI monotherapy in patients with treatment-na...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Biomed Res Int
Главные авторы: Ma, Jie-Tao, Guo, Yi-Jia, Song, Jun, Sun, Li, Zhang, Shu-Ling, Huang, Le-Tian, Jing, Wei, Zhao, Jian-Zhu, Han, Cheng-Bo
Формат: Artigo
Язык:Inglês
Опубликовано: Hindawi 2021
Предметы:
Research Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7861921/
https://ncbi.nlm.nih.gov/pubmed/33575349
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2021/8850256
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы